AG
STJ

Aperio Group’s St Jude Medical STJ Stock Holding History

Aperio Group’s Portfolio STJ Stock Details STJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-97,344
Closed -$7.81M – 2215
2016
Q4 		$7.81M Sell
97,344
-11,337
-10% -$900K 0.06% 376
2016
Q3 		$8.67M Buy
108,681
+4,852
+5% +$392K 0.06% 357
2016
Q2 		$8.1M Buy
103,829
+25,027
+32% +$1.78M 0.06% 349
2016
Q1 		$4.33M Buy
78,802
+8,389
+12% +$457K 0.04% 528
2015
Q4 		$4.35M Sell
70,413
-13,306
-16% -$839K 0.04% 504
2015
Q3 		$5.28M Buy
83,719
+3,850
+5% +$275K 0.05% 409
2015
Q2 		$5.84M Buy
79,869
+12,852
+19% +$928K 0.06% 369
2015
Q1 		$4.38M Buy
67,017
+7,798
+13% +$519K 0.05% 445
2014
Q4 		$3.85M Buy
59,219
+4,693
+9% +$302K 0.05% 457
2014
Q3 		$3.28M Buy
54,526
+2,012
+4% +$131K 0.04% 474
2014
Q2 		$3.64M Sell
52,514
-1,904
-3% -$123K 0.05% 420
2014
Q1 		$3.56M Buy
+54,418
New +$3.54M 0.05% 486
2013
Q4 		– Sell
-38,393
Closed -$2.22M – 500
2013
Q3 		$2.06M Buy
38,393
+6,212
+19% +$320K 0.04% 577
2013
Q2 		$1.47M Buy
+32,181
New +$1.39M 0.03% 611

Other funds holding STJ

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return
JWA
JFS Wealth Advisors Hermitage, Pennsylvania $2.01B AUM 21.74% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Aperio Group's STJ Position: Q1 2017 in Review

Aperio Group sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 97,344 shares — an estimated $7.81M sold.

Aperio Group first reported a position in STJ in Q2 2013 and held it in 14 quarters. The position peaked at $8.67M in Q3 2016. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • Aperio Group reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • Aperio Group sold 97,344 St Jude Medical shares in Q1 2017, an estimated $7.81M.
  • Aperio Group first reported a position in St Jude Medical in Q2 2013 and held it in 14 quarters.
  • Aperio Group's St Jude Medical position peaked at $8.67M in Q3 2016.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on Aperio Group's 13F filing for Q1 2017, filed 5 May 2017.